The expression of estrogen receptors ERα and ERβ changes in different stages of the prostate cancer and conflicting findings on the roles of these receptors in the prostate cancer continue to emerge [reviewed by (11–15)]. The gene discussed is ESR2; the disease is prostate cancer.